{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T01:09:20Z","timestamp":1773450560133,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jfma.2024.08.001","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T16:22:34Z","timestamp":1722702154000},"page":"712-717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of completely histological remission on reducing flare-ups in moderate-to-severe, biologics-experienced ulcerative colitis patients with endoscopic remission"],"prefix":"10.1016","volume":"124","author":[{"given":"Zih-Hao","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren-Chin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Jung","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horng-Yih","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pai-Jui","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7829-1504","authenticated-orcid":false,"given":"Chien-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Tang","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Kuan","family":"Tsou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Wang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2004-1526","authenticated-orcid":false,"given":"Yu-Bin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1100-5371","authenticated-orcid":false,"given":"Puo-Hsien","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jfma.2024.08.001_bib1","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.mayocp.2019.01.018","article-title":"Ulcerative colitis","volume":"94","author":"Feuerstein","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.jfma.2024.08.001_bib2","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2021.10.035","article-title":"Colorectal cancer in inflammatory bowel disease: mechanisms and management","volume":"162","author":"Shah","year":"2022","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jfma.2024.08.001_bib3","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jfma.2024.08.001_bib4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/gut.32.2.174","article-title":"Microscopic activity in ulcerative colitis: what does it mean?","volume":"32","author":"Riley","year":"1991","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.jfma.2024.08.001_bib5","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/ajg.2016.418","article-title":"Histological disease activity as a predictor of clinical relapse among patients with ulcerative colitis: systematic review and meta-analysis","volume":"111","author":"Park","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jfma.2024.08.001_bib6","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/apt.16026","article-title":"Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing","volume":"52","author":"Jangi","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.jfma.2024.08.001_bib7","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/ibd\/izab340","article-title":"Histologic evaluation using the Robarts Histopathology index in patients with ulcerative colitis in deep remission and the association of histologic remission with risk of relapse","volume":"28","author":"Park","year":"2022","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"10.1016\/j.jfma.2024.08.001_bib8","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.cgh.2017.02.016","article-title":"Histologic normalization occurs in ulcerative colitis and is associated with improved clinical outcomes","volume":"15","author":"Christensen","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jfma.2024.08.001_bib9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/gutjnl-2015-309598","article-title":"Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up","volume":"65","author":"Bryant","year":"2016","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.jfma.2024.08.001_bib10","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/MCG.0000000000001681","article-title":"Histologic remission (NANCY index) is superior to endoscopic mucosal healing in predicting relapse free survival in patients with ulcerative colitis in clinical and endoscopic remission","volume":"57","author":"Wang","year":"2023","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.jfma.2024.08.001_bib11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1053\/j.gastro.2007.08.001","article-title":"Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study","volume":"133","author":"Gupta","year":"2007","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jfma.2024.08.001_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/DCR.0b013e31819ad456","article-title":"Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis","volume":"52","author":"Hefti","year":"2009","journal-title":"Dis Colon Rectum"},{"issue":"9","key":"10.1016\/j.jfma.2024.08.001_bib13","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/ibd.21268","article-title":"Mucosal healing as an index of colitis activity: back to histological healing for future indices","volume":"16","author":"Korelitz","year":"2010","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.jfma.2024.08.001_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2013.07.022","article-title":"Histologic remission: the ultimate therapeutic goal in ulcerative colitis?","volume":"12","author":"Peyrin-Biroulet","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jfma.2024.08.001_bib15","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1053\/j.gastro.2011.01.057","article-title":"Intestinal inflammation and cancer","volume":"140","author":"Ullman","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jfma.2024.08.001_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2023-001218","article-title":"Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trial","volume":"11","author":"Jairath","year":"2024","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.jfma.2024.08.001_bib17","author":"Administration"},{"issue":"1","key":"10.1016\/j.jfma.2024.08.001_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cgh.2019.07.005","article-title":"Ulcerative colitis and Crohn's disease have similar burden and goals for treatment","volume":"18","author":"Le Berre","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jfma.2024.08.001_bib19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2003.11.010","article-title":"Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis","volume":"126","author":"Rutter","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jfma.2024.08.001_bib20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cgh.2019.05.002","article-title":"Nancy index scores of chronic inflammatory bowel disease activity associate with development of colorectal neoplasia","volume":"18","author":"Kirchgesner","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.jfma.2024.08.001_bib21","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/ibd\/izz333","article-title":"Histologic healing in ulcerative colitis: benefits. And risks. Was voltaire right?","volume":"26","author":"Kornbluth","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jfma.2024.08.001_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/17562848221140659","article-title":"Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis","volume":"15","author":"Steinsb\u00f8","year":"2022","journal-title":"Therap Adv Gastroenterol"},{"issue":"11","key":"10.1016\/j.jfma.2024.08.001_bib23","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/ibd\/izz308","article-title":"Histological markers of clinical relapse in endoscopically quiescent ulcerative colitis","volume":"26","author":"Kevans","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.jfma.2024.08.001_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.gastro.2022.10.014","article-title":"Intestinal barrier healing is superior to endoscopic and histologic remission for predicting major adverse outcomes in inflammatory bowel disease: the prospective ERIca trial","volume":"164","author":"Rath","year":"2023","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jfma.2024.08.001_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/apt.15568","article-title":"Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission","volume":"51","author":"Cushing","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.jfma.2024.08.001_bib26","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1097\/MIB.0000000000001275","article-title":"Impact of histological and endoscopic remissions on clinical recurrence and recurrence-free time in ulcerative colitis","volume":"23","author":"Ponte","year":"2017","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.jfma.2024.08.001_bib27","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1053\/j.gastro.2020.01.006","article-title":"AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis","volume":"158","author":"Feuerstein","year":"2020","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jfma.2024.08.001_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000522569","article-title":"Elderly patients with moderate-to-severe ulcerative colitis are more likely to have treatment failure and adverse outcome","volume":"69","author":"Zhang","year":"2023","journal-title":"Gerontology"},{"issue":"5","key":"10.1016\/j.jfma.2024.08.001_bib29","article-title":"Histologic scoring indices for evaluation of disease activity in ulcerative colitis","volume":"5","author":"Mosli","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jfma.2024.08.001_bib30","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1053\/j.gastro.2020.06.043","article-title":"Incremental benefit of achieving endoscopic and histologic remission in patients with ulcerative colitis: a systematic review and meta-analysis","volume":"159","author":"Yoon","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jfma.2024.08.001_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/ecco-jcc\/jjv180","article-title":"Mucosal healing in ulcerative colitis--when zero is better","volume":"10","author":"Boal Carvalho","year":"2016","journal-title":"J Crohns Colitis"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664624003528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664624003528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:32:58Z","timestamp":1762331578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664624003528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0929664624003528"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2024.08.001","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of completely histological remission on reducing flare-ups in moderate-to-severe, biologics-experienced ulcerative colitis patients with endoscopic remission","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2024.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}